Intravitreal ranibizumab injections for the treatment of choroidal neovascularization complicating high myopia;Néovaisseaux choroïdiens du myope fort: traitement par injection intravitréenne de ranibizumab

Journal Francais d'Ophtalmologie

Volumn 33, Issue 9, 2010, Pages 649-654

  Ouhadj, O ^a   Bouarfa, A ^a   Akel, S ^a   Mendil, L ^a   Nebab, A ^a   Nouri, M T ^a  

^a Centre Hospitalier et Universitaire de Beni Messous Algiers   (Algeria)

Author keywords

Choroidal neovascularization; High myopia; Ranibizumab

Indexed keywords

MONOCLONAL ANTIBODY; RANIBIZUMAB;

ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MYOPIA; PROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION;

ADULT; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; MYOPIA; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79954629347     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfo.2010.09.004     Document Type: Article

References (19)

1. B.T. Curtin The myopias 1985 Harper and Row Philadelphia p. 240-3
2. S.Y. Cohen, A. Laroche, Y. Leguen, G. Soubrane, and G.J. Coscas Etiology of choroidal neovascularization in young patients Ophthalmology 103 1996 1241 1244
3. P. Van Wijngaarden Inhibitors of ocular neovascularization: promises and potential problems JAMA 293 2005 1509 1513
4. K.J. Blinder, M.S. Blumenkranz, N.M. Bressler, S.B. Bresler, G. Donato, and H. Lewis Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial - VIP report no.3 Ophthalmology 110 2003 667 673
5. J.P. Tong, W.M. Chan, D.T. Liu, T.Y. Lai, K.W. Choy, and C.P. Pang Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization Am J Ophthalmol 141 2006 456 462
6. Chan WM, Lai TY, Liu DT, Lam DSC. Intravitreal bevacizumab for myopic choroidal neovascularization: 1-year results of prospective pilot study. Ophthalmology 2007;114:2190-6.
7. J.M. Ruiz-Moreno, J.A. Montero, F. Gomez Ulla, and S. Ares Intravitreal bevacizumab to treat subfoveal choroidal neovascularization in highly myopic eyes: 1-year outcome Br J Ophthalmol 93 2009 448 451
8. ®) for choroidal neovascularization secondary to pathological myopia: 6-month results Br J Ophthalmol 92 2008 1035 1039
9. H. Sakaguchi, Y. Ikumo, F. Gomi, M. Kamei, M. Sawa, and M. Tsujikawa Intravitreal injection of bevacizumab of choroidal neovascularization associated with pathological myopia Br J Ophthalmol 91 2007 161 165 (Pubitemid 46202863)
10. D.J. Rosenfeld Intravitreal avastin for choroidal neovascularization in pathological myopia: the controversy continues Br J Ophthalmol 91 2007 128 130
11. o 01].
12. o 01].
13. L. Konstantinidis, I. Mantel, A. Ambresin, J.A. Pournaras, and L. Zografos Intravitreal ranibizumab for the treatment of myopic choroidal neovascularization Graefes Arch Clin Exp Ophthalmol 247 2009 311 318
14. o 01].
15. o 01].
16. F. Lalloum, E. Souied, S. Bastuji-Garin, N. Puche, G. Querques, and A. Glacet-Bernard Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia Retina 30 2010 399 406
17. R. Silva, J. Ruiz-Moreno, P. Rosa, A. Carneiro, J. Nascimento, and L. Rito Intravitreal ranibizumab for myopic choroidal neovascularization: 12-month results Retina 30 2010 407 412
18. M. Varano, M. Tedeschi, F. Oddone, L. Perillo, A.M. Copp, and M.C. Parravano Microperimetric retinal changes in myopic choroidal neovascularization treated with intravitreal ranibizumab Retina 30 2010 413 417
19. L. Wu, M.A. Martinez-Castellanes, and H. Quiroz-Mercado Twelve-month safety of intravitreal injections of bevacizumab: results of the Pan-American Collaborative Retina Study Group (PACORES) Graefes Arch Clin Exp Ophthalmol 246 2008 81 87